Purpose: Fuchs dystrophy is the leading indication of corneal transplantation in the United States. A CTG18.1 trinucleotide repeat in TCF4 correlates with increased severity in Fuchs dystrophy; however, quantitative estimates of increased transplantation risk, including effects of age and sex, are unclear.
F uchs corneal dystrophy (FCD) is a hereditary progressive condition associated with corneal endothelial cell loss and development of guttae, excrescences of Descemet membrane. As the leading cause of corneal transplantation in the United States, 1 it affects approximately 1 of every 25 Americans older than 40 years. 2 Symptoms begin as blurry morning vision in middle age and loss of contrast sensitivity, eventually resulting in vision loss secondary to corneal edema and development of painful epithelial bullae. Endothelial keratoplasty is curative and has increased yearly over the past decade to 30,710 cases in 2015 in the United States. 1 Previously, Wieben et al demonstrated a strong association between intronic trinucleotide repeat expansion in TCF4 and Fuchs dystrophy, 3 after association with the singlenucleotide polymorphism rs613872, a variant also identified within the same gene. 4 Data on a population sample from Tangier island suggested higher severity among affected individuals with the rs613872 single-nucleotide polymorphism, 5 and we and others have found in large case-control studies that expansion of the trinucleotide repeat in TCF4 correlates strongly with both disease status and severity of Fuchs dystrophy. 6, 7 Given the social and economic costs of corneal transplantation, understanding its associated risk factors and their impact would be beneficial to patient counseling and management. Here, we describe the association of the TCF4 trinucleotide repeat with corneal transplantation in a crosssectional analysis of 574 cases of Fuchs dystrophy and explore the associated time to surgery.
MATERIALS AND METHODS

Recruitment
A total of 574 participants were enrolled in a longitudinal study of Fuchs dystrophy after slit-lamp biomicroscopy by an anterior segment specialist revealed clinically significant disease, or if the patient reported a history of Fuchs dystrophy and had undergone corneal transplantation, in the form of either penetrating or endothelial keratoplasty. Clinically significant disease was defined as a minimum of 5 central guttae in both eyes.
All study participants consented to the study protocol approved by the Joint Committee on Clinical Investigation at the Johns Hopkins University School of Medicine and in accordance with the Declaration of Helsinki and Health Insurance Portability and Accountability Act regulations.
Written informed consent was obtained from all individuals before enrollment.
All participants provided a blood sample, and genomic DNA was extracted from leukocytes using the Qiagen DNeasy Blood & Tissue Kit (Qiagen, Valencia, CA).
Sequencing
Sequencing was performed as previously described. 6 Briefly, the 59 forward primer (P1), labeled with 6-FAM (59 CAGATGAGTTTGGTGTAAGATG 39), and the unlabeled reverse primer (P2) (59 TTGCAGCCCCTTTCTGCTTGT 39) were used in polymerase chain reaction (PCR) amplification which was performed using Platinum PCR SuperMix High Fidelity (Life Technologies, Carlsbad, CA). Cycling conditions were applied as described by Wieben et al. 3 Triplet repeat primed PCR (TP-PCR) reactions were performed with 1 mL of genomic DNA mixed with 14 mL of Platinum PCR SuperMix High Fidelity (Life Technologies) and 250 nM final concentration of P1 and reverse primer (P4) (59 TACGCATCCCAGTTTGAGACGCAGCAGCAGCAG-CAG 39) at 95°C for 5 minutes; (95°C: 30 seconds; 58°C: 1 minute; 68°C: 4 minutes) · 20 cycles, and 68°C for 10 minutes. An additional 15 seconds was introduced in each of the 8th to 20th cycles. Two microliters of PCR product was used as a template for a second PCR reaction by mixing with 13 mL of the Platinum PCR SuperMix with 250 nM final concentration of the 6-FAM-labeled forward primer and the unlabeled reverse primer (P3) (59 TACGCATCCCAGTTT-GAGACG 39). The reverse primer of the second PCR step binds to the adapter sequence on P4 that is nonhomologous to human genomic DNA. The second PCR was cycled at 95°C for 5 minutes; (95°C: 30 seconds; 62°C: 1 minute; 68°C: 6 minutes) · 25 cycles, and 68°C for 10 minutes.
PCR products were resolved using the ABI3730XL DNA Analyzer (Applied Biosystems Inc, Foster City, CA) with GeneScan 500 LIZ dye size standard mix. The results were analyzed using GeneMapper (Applied Biosystems Inc).
Statistical Analyses
We employed a cross-sectional approach on a cohort of 574 patients for which we had previously identified a strong association between the CTG repeat in TCF4 and affection with Fuchs Dystrophy. Demographic information was provided by participants, which included race, age, and sex.
To test for association with age, Student t tests were conducted to compare the mean age for participants with and without surgery, and x 2 tests were conducted to assess the association between sex and surgery. To test for the effect of laterality, a mixed-effects logistic regression model with a random intercept for patients was used. The random intercept was used to account for the correlation between eyes for bilateral patients.
We used logistic regression to assess the relation of age, sex, and expanded repeat status with surgery status. Odds ratios and 95% confidence intervals were calculated.
To explore the timing of surgery with respect to age between expanded and nonexpanded repeats in patients undergoing surgery, Kaplan-Meier survival curves were estimated, and Cox proportional hazard regression modeling was performed to assess equality in survival functions.
All analyses were performed using STATA version 14.0 (Stata Statistical Software; College Station, TX). A P value less than or equal to 0.05 is treated as statistical significance.
RESULTS
Of 574 participants affected by Fuchs dystrophy, 106 individuals (18.5%) had undergone corneal transplantation in at least one eye at the time of the initial visit. There was no difference in the probability of having surgeries between right (85 eyes, 14.8%) and left (71 eyes, 12.4%) eyes (odds ratio = 0.64; P = 0.082, mixed-effects logistic regression). A total of 51 participants had surgery in both eyes.
A total of 26 African Americans with Fuchs dystrophy participated in the study (4.5% of total sample), of which 3 (11.5%) had undergone corneal transplantation at the time of enrollment. Two participants self-identified as Asian (0/2, 0 posttransplant) and 546 as white (103/546, 18.9% posttransplant). The difference in proportions of African American and white patients undergoing surgery was not significant (P = 0.45).
The mean age of participants who had undergone surgery (68.4 years old) and those who had not at the time of the initial visit (67.7 years old) was not significantly different (P = 0.29), nor was the difference in ages between those without and with repeat expansion (67.0 vs. 68.3, respectively, P = 0.21).
Although the participants were predominantly women (64.8% vs. 35.2%), there was no association between sex and surgery (19.8% of men vs. 17.7% of women had undergone corneal transplantation, P = 0.54).
As demonstrated in Table 1 , a higher proportion of participants who had undergone surgery at the time of enrollment demonstrated an expanded allele (78/106, 73.6%) compared with those who had not undergone surgery (279/468, 59.6%), a significant difference (P = 0.007). Relative proportions of repeat size in surgical and nonsurgical patients are illustrated in Figure 1 .
Kaplan-Meier survival estimates were produced (Fig. 2) , and a proportional hazard Cox regression model was performed to explore progression of transplantation with respect to age in patients with and without the expanded repeat while accounting for sex. The data demonstrated a significant difference in survivor functions related to repeat status (P = 0.027) with a hazard ratio of 1.64 (95% confidence interval, 1.06-2.55), but sex did not show a significant effect on 
DISCUSSION
Here, we demonstrate that expansion of the CTG18.1 trinucleotide repeat in TCF4 is associated with a higher risk of corneal transplantation at a younger age, assessed for the first time in a multiracial population sample from the United States.
The increased likelihood of corneal transplantation at a given age seen with the expanded TCF4 repeat allele is consistent with previous findings demonstrating increased severity of disease from this genetic lesion among affected individuals studied by both our group 6 and others. 7 An association found between the expanded allele and corneal transplantation in a white sample 7 raises questions about the impact of an expanded repeat and sex on the timing of transplantation. 8 Here, the association is significant using a statistical methodology that accounts for both sex and age.
Understanding the increased likelihood of transplantation among those harboring the expanded TCF4 repeat may be particularly relevant for patient counseling in the future. The position of Fuchs dystrophy as the leading indication of corneal transplantation in the United States 1 adds particular relevance to the possible benefits of acquiring such information for patients. Although the decision to pursue surgery is a complex one that is based on multiple factors associated with visual function, potential applications in the future for genetic status include individualized tailoring of routine visit intervals before surgery and counseling regarding prognosis.
Although the odds of an expanded TCF4 repeat were higher in patients who underwent transplantation, not all posttransplant patients harbored the expanded allele. This may reflect the fact that classic Fuchs dystrophy is a disease of late onset, and the pathway causative for disease has multiple inputs. We have previously demonstrated a family in which individuals with both FCD4 disease allele and p.Q840P mutation in TCF8 underwent corneal transplantation, whereas those with only a single disease allele demonstrated mild disease. 9 Families associated with the FCD1 10 and FCD2 11 loci and causative mutations in SLC4A11, 12 LOXHD1, 13 and FIGURE 1. Proportion of subjects who had undergone corneal transplantation at the time of enrollment in a longitudinal study of Fuchs corneal dystrophy by repeat expansion status. The number of trinucleotide repeats, listed on the x axis, represents the designated number of repeats up to the following interval (eg, "30" includes participants with repeat sizes from 30 to 39). FIGURE 2. Estimated survival curves depicting relative differences in the age of surgery between patients with less than 40 repeats (NN) versus greater than 40 repeats in either allele (NX/XX), constructed from clinical data. The Cox proportional hazard regression model demonstrates a significant difference in survival function (P = 0.027), with a hazard ratio of 1.64 (95% confidence interval, 1.05-2.55) but without a significant association with sex (P = 0.747). ABGL1 14 have also had members who underwent corneal transplantation, suggesting a role for additional genetic factors associated with progression to transplantation.
In this study, the proportion of patients who underwent corneal transplantation from white and African American backgrounds was not found to be significantly different; further analyses in a larger cohort of African American patients will provide additional insight into whether true disparities exist in clinical practice.
In summary, we demonstrate that in comparison with patients without the expanded allele, expansion of the trinucleotide repeat in TCF4 is associated with 1.64 times greater likelihood of corneal transplantation at a given age in a large cohort of patients with Fuchs dystrophy.
